These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant medical therapy for colorectal cancer. Diaz-Canton EA; Pazdur R Surg Clin North Am; 1997 Feb; 77(1):211-28. PubMed ID: 9092111 [TBL] [Abstract][Full Text] [Related]
4. Role of combined-modality therapy in the management of locally advanced rectal cancer. Hosein PJ; Rocha-Lima CM Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689 [TBL] [Abstract][Full Text] [Related]
5. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
6. Rectal cancer radiotherapy. Ramsey S; Tepper JE Cancer J; 2007; 13(3):204-9. PubMed ID: 17620771 [TBL] [Abstract][Full Text] [Related]
7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for colon and rectal cancer. Ratkin GA Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147 [TBL] [Abstract][Full Text] [Related]
9. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center. Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410 [TBL] [Abstract][Full Text] [Related]
11. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Moore HG; Riedel E; Minsky BD; Saltz L; Paty P; Wong D; Cohen AM; Guillem JG Ann Surg Oncol; 2003; 10(1):80-5. PubMed ID: 12513965 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Mohiuddin M; Hayne M; Regine WF; Hanna N; Hagihara PF; McGrath P; Marks GM Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1075-80. PubMed ID: 11072165 [TBL] [Abstract][Full Text] [Related]
13. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868 [TBL] [Abstract][Full Text] [Related]
14. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas. Larsen SG; Wiig JN; Giercksky KE Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173 [TBL] [Abstract][Full Text] [Related]
15. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Kim HK; Jessup JM; Beard CJ; Bornstein B; Cady B; Stone MD; Bleday R; Bothe A; Steele G; Busse PM Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):777-83. PubMed ID: 9240646 [TBL] [Abstract][Full Text] [Related]
16. Role of adjuvant therapy in surgically resected colorectal carcinoma. Sinicrope FA; Sugarman SM Gastroenterology; 1995 Sep; 109(3):984-93. PubMed ID: 7657129 [TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
18. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450 [TBL] [Abstract][Full Text] [Related]
19. Abdominoperineal resection for rectal cancer at a specialty center. Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560 [TBL] [Abstract][Full Text] [Related]